MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.jjcc.2016.08.004

Медицинская библиотека · Journal of cardiology · 2016

Potential roles of the wearable cardioverter-defibrillator in acute phase care of patients at high risk of sudden cardiac death: A single-center Japanese experience.

Sasaki Shingo, Shoji Yoshihiro, Ishida Yuji, Kinjo Takahiko, Tsushima Yuichi, Seno Maiko, Nishizaki Fumie, Itoh Taihei, Izumiyama Kei, Yokota Takashi, Yokoyama Hiroaki, Yamada Masahiro, Horiuchi Daisuke, Kimura Masaomi, Higuma Takumi, Tomita Hirofumi, Okumura Ken

Оценочное исследованиеСтатьяПеревод пока не подготовлен

Аннотация

BACKGROUND

The wearable cardioverter-defibrillator (WCD) has been expected to play a role as an effective bridge therapy to implantable cardioverter-defibrillator (ICD) implantation in patients at high risk of ventricular tachyarrhythmias (VA). Although WCD has been available since April 2014 in Japan, its usefulness remains unclear.

METHODS AND

RESULTS

During the early period after hospitalization, patients at high risk of VA after excluding some elderly patients were prescribed WCD. The consecutive 50 patients with WCD use (median age 56 years, 38 for secondary prevention) were studied. We analyzed clinical efficacy and safety of WCD, and examined its potential roles. Of the 50 patients, 38 used WCD only during hospitalization. During WCD use [median 16 (IQR 8-33) days], all patients wore WCD for 98% of a day regardless of in or out-of-hospital use. Sustained VA was detected in 4 patients (8%; for primary prevention in 1) with 7 episodes, and 6 of 7 episodes required shock therapy. Of the 6 shock therapies, 4 were for sustained ventricular tachycardia with the median rate of 236beats/min (IQR 203-250), and the other 2 for ventricular fibrillation. Subsequently, only 27 patients (54%) of all underwent ICD implantation following the WCD use, because of reduced risk of VA after optimal pharmacological therapy or improvement in the left ventricular function.

CONCLUSIONS

The WCD use for the acute phase care of patients at high risk of VA can be safe and effective, and may be useful for evaluating indication of ICD implantation.

Для цитирования: Sasaki Shingo, Shoji Yoshihiro, Ishida Yuji, Kinjo Takahiko, Tsushima Yuichi, Seno Maiko, Nishizaki Fumie, Itoh Taihei, Izumiyama Kei, Yokota Takashi, Yokoyama Hiroaki, Yamada Masahiro, Horiuchi Daisuke, Kimura Masaomi, Higuma Takumi, Tomita Hirofumi, Okumura Ken. Potential roles of the wearable cardioverter-defibrillator in acute phase care of patients at high risk of sudden cardiac death: A single-center Japanese experience.. Journal of cardiology. 2016. DOI: 10.1016/j.jjcc.2016.08.004.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.